Literature DB >> 20213370

Drug-drug interactions and adverse drug reactions: separating the wheat from the chaff.

Munir Pirmohamed1.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20213370     DOI： 10.1007/s00508-010-1309-1

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN： 0043-5325            Impact factor:   1.704


× No keyword cloud information.
  25 in total

Review 1.  Joining the DoTS: new approach to classifying adverse drug reactions.

Authors:  J K Aronson; R E Ferner
Journal:  BMJ       Date:  2003-11-22

Review 2.  Safety of statins: focus on clinical pharmacokinetics and drug interactions.

Authors:  Stefano Bellosta; Rodolfo Paoletti; Alberto Corsini
Journal:  Circulation       Date:  2004-06-15       Impact factor: 29.690

3.  EIDOS: a mechanistic classification of adverse drug effects.

Authors:  Robin E Ferner; Jeffrey K Aronson
Journal:  Drug Saf       Date:  2010-01-01       Impact factor: 5.606

4.  Decade-long changes in the use of combination evidence-based medical therapy at discharge for patients surviving acute myocardial infarction.

Authors:  Frederick A Spencer; Darleen Lessard; Jorge Yarzebski; Joel M Gore; Robert J Goldberg
Journal:  Am Heart J       Date:  2005-10       Impact factor: 4.749

5.  National surveillance of emergency department visits for outpatient adverse drug events.

Authors:  Daniel S Budnitz; Daniel A Pollock; Kelly N Weidenbach; Aaron B Mendelsohn; Thomas J Schroeder; Joseph L Annest
Journal:  JAMA       Date:  2006-10-18       Impact factor: 56.272

6.  The completeness of medication histories in hospital medical records of patients admitted to general internal medicine wards.

Authors:  H S Lau; C Florax; A J Porsius; A De Boer
Journal:  Br J Clin Pharmacol       Date:  2000-06       Impact factor: 4.335

7.  Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study.

Authors:  David N Juurlink; Muhammad M Mamdani; Douglas S Lee; Alexander Kopp; Peter C Austin; Andreas Laupacis; Donald A Redelmeier
Journal:  N Engl J Med       Date:  2004-08-05       Impact factor: 91.245

Review 8.  Simplification strategies to reduce antiretroviral drug exposure: progress and prospects.

Authors:  John E McKinnon; John W Mellors; Susan Swindells
Journal:  Antivir Ther       Date:  2009

9.  A 30-year perspective (1975-2005) into the changing landscape of patients hospitalized with initial acute myocardial infarction: Worcester Heart Attack Study.

Authors:  Kevin C Floyd; Jorge Yarzebski; Frederick A Spencer; Darleen Lessard; James E Dalen; Joseph S Alpert; Joel M Gore; Robert J Goldberg
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2009-03-05

10.  Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes.

Authors:  Emma C Davies; Christopher F Green; Stephen Taylor; Paula R Williamson; David R Mottram; Munir Pirmohamed
Journal:  PLoS One       Date:  2009-02-11       Impact factor: 3.240
View more
  7 in total

1.  Data-driven prediction of drug effects and interactions.

Authors:  Nicholas P Tatonetti; Patrick P Ye; Roxana Daneshjou; Russ B Altman
Journal:  Sci Transl Med       Date:  2012-03-14       Impact factor: 17.956

2.  UPLC-MS/MS Measurement of the Effect of Isavuconazole, Itraconazole and Fluconazole on the Pharmacokinetics of Selinexor in Rats.

Authors:  Shuang-Long Li; Yi Zhang; Qian-Shi Cheng; Jun-Zhe Xin; Ze-Qin Dong; Xiang-Jun Qiu
Journal:  Infect Drug Resist       Date:  2020-09-14       Impact factor: 4.003

3.  Systematic prediction of drug combinations based on clinical side-effects.

Authors:  Hui Huang; Ping Zhang; Xiaoyan A Qu; Philippe Sanseau; Lun Yang
Journal:  Sci Rep       Date:  2014-11-24       Impact factor: 4.379

4.  Multimorbidity, polypharmacy, and drug-drug-gene interactions following a non-ST elevation acute coronary syndrome: analysis of a multicentre observational study.

Authors:  R M Turner; E M de Koning; V Fontana; A Thompson; M Pirmohamed
Journal:  BMC Med       Date:  2020-11-25       Impact factor: 8.775

5.  Prevalence, beliefs and impact of drug-drug interactions between antiretroviral therapy and illicit drugs among people living with HIV in Spain.

Authors:  Vanessa Castro-Granell; Noé Garin; Ángeles Jaén; Santiago Cenoz; María José Galindo; María José Fuster-RuizdeApodaca
Journal:  PLoS One       Date:  2021-11-19       Impact factor: 3.240

6.  Potential drug-drug interactions in HIV-infected children on antiretroviral therapy in Lagos, Nigeria.

Authors:  Kazeem A Oshikoya; Ibrahim A Oreagba; Saheed Lawal; Olufunsho Awodele; Olayinka O Ogunleye; Idowu O Senbanjo; Sunday O Olayemi; Veronica C Ezeaka; Edamisan O Temiye; Titilope A Adeyemo; Oluranti Opanuga; Olufunmilayo A Lesi; Sulaimon A Akanmu
Journal:  HIV AIDS (Auckl)       Date:  2014-04-05

7.  High Risk of Drug-drug interactions among Hospitalized Patients with kidney Diseases at a Nigerian Teaching Hospital: A Call for Action.

Authors:  Abdulwasiu Adeniyi Busari; Ibrahim A Oreagba; Kazeem A Oshikoya; Mary O Kayode; Sunday O Olayemi
Journal:  Niger Med J       Date:  2020-02-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.